Media kits

Sep 18, 2020

MiniMed® 670G Hybrid Closed Loop System

Information about the MiniMed® 670G system, the world’s first hybrid closed loop system for individuals with type 1 diabetes.

The following media kits are made available to provide reporters with background information on the range of Medtronic therapies and the conditions they treat.

	May 28, 2019 MiniMed(TM) 670G System Real-World Data on 8 Million Patient Days Shows 71 Percent Time in Range Across All Age Groups DUBLIN - May 28, 2019 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced real-world clinical outcomes for the MiniMed(TM) 670G system, which is being used by more...
	Jun 24, 2018 MiniMed 670G System Real-World Data Show Improved Time in Range and Reduced Lows and Highs Across All Patient Groups Including a 41 Percent Time in Range Improvement for Previous MDI Patients GLOBE NEWSWIRE via COMTEX) --DUBLIN - June 24, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced real-world clinical outcomes for 32,178 users of the...
	Jun 21, 2018 Medtronic Receives FDA Approval of New Pediatric Indication for the MiniMed(TM) 670G Hybrid Closed Loop System in Children Ages 7-13 (GLOBE NEWSWIRE via COMTEX) --DUBLIN- June 21, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that the U.S. Food and Drug Administration (FDA) has...
	Jun 7, 2017 Medtronic Initiates U.S. Launch of World's First Hybrid Closed Loop System for Type 1 Diabetes The MiniMed(TM) 670G System Features the Company's Most Advanced SmartGuard(TM)HCL Technology and New Guardian(TM) Sensor 3 DUBLIN - June 7, 2017 - Medtronic plc (NYSE:MDT), today announced the U.S. launch of the MiniMed(TM) 670G system - the world's first Hybrid Closed Loop system for people with type 1 diabetes....
	Sep 28, 2016 Medtronic Receives FDA Approval for World's First Hybrid Closed Loop System for People with Type 1 Diabetes The MiniMed® 670G System Features the Company's Most Advanced SmartGuard(TM) Algorithm To-Date DUBLIN - Sept. 28, 2016 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval of its MiniMed® 670G...